Chapter 4: Illicit Drug Usage in the United States 3 Contact Hours
By: Kelly A. Crum PhD(c), MSN, RN and Marianna E. Pascuzzi, CPhT Author Disclosure: Kelly A. Crum PhD(c), Marianna E. Pascuzzi, CPh , and Colibri Healthcare, LLC do not have any actual or potential conflicts of interest in relation to this lesson. Universal Activity Number UAN: 0607-0000-23-023-H04-T
Questions regarding statements of credit and other customer service issues should be directed to 1-888-666-9053. This lesson is $19.95. Colibri Healthcare, LLC is accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile
Activity Type: Knowledge-based Initial Release Date: 11/21/2023 Expiration Date: 11/21/2026
information will have their credit for 3 contact hours (0.3 CEU) submitted to CPE Monitor as early as within 10 business days after course completion and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Describe the impact the COVID-19 pandemic has had on drug abuse and overdoses. Discuss how abusing drugs influences the patient outcomes who develop COVID-19. Describe priorities for assessment and care when dealing with a patient who has abused drugs. Describe at least three elements of the national drug control strategy. implicit bias in healthcare is crucial for achieving equity in medical treatment. Strategies to combat these biases involve education and awareness programs for healthcare professionals. These programs help individuals recognize and acknowledge their biases, fostering a more empathetic and unbiased approach to patient care. Additionally, implementing policies and procedures prioritizing equitable treatment for all patients can play a pivotal role in reducing healthcare disparities. Ultimately, confronting implicit bias in healthcare is essential to creating a more just and equitable healthcare system where everyone receives fair and equal treatment regardless of their background or characteristics.
Target Audience: Pharmacists in a community-based setting. To Obtain Credit: A minimum test score of 75 percent is needed to obtain a credit. Please submit your answers either by mail, fax, or online at EliteLearning.com/Book
Learning objectives After completing this course, the learner should be able to: State the severity of drug abuse in the United States. Differentiate between club and prescription drug abuse. List five club drugs and associated street names. Identify the most frequently abused prescription drug types and examples of each type. Describe three new emerging drug trends. Implicit bias in healthcare Implicit bias significantly affects how healthcare professionals perceive and make treatment decisions, ultimately resulting in disparities in health outcomes. These biases, often unconscious and unintentional, can shape behavior and produce differences in medical care along various lines, including race, ethnicity, gender identity, sexual orientation, age, and socioeconomic status. Healthcare disparities stemming from implicit bias can manifest in several ways. For example, a healthcare provider might unconsciously give less attention to a patient or make assumptions about their medical needs based on race, gender, or age. The unconscious assumptions can lead to delayed or inadequate care, misdiagnoses, or inappropriate treatments, all of which can adversely impact health outcomes. Addressing Introduction Despite individual and federal efforts to curb drug abuse, healthcare professionals care for patients who have drug problems every day. This course will offer information that
may help the healthcare workers to understand the drug crisis in America, as well as provide strategies to help healthcare professionals deal with individuals struggling with addiction.
OVERDOSE DRUG DEATHS
Deaths from drug use can be divided into two categories: prescription drugs and illicit, or “street,” drugs. The statistics tell the story. In 2021, 106,699 people died of drug-involved causes (National Institute on Drug Abuse, NIDA, 2023). This number is up by 36,069 individuals since 2019. In 2019, 14,139 drug- involved deaths were from prescription opioids. That number has increased to 16,706 in 2021 (NIDA, 2023). Deaths involving synthetic opioids other than methadone are continually rising, with 70,601 overdose deaths reported in 2021. Fentanyl is still the leading cause of drug overdoses (NIDA, 2023). According
to NIDA, heroin-related deaths increased from 1,960 in 1999 to 15,482 in 2017, trending downward in 2021 to 9,173. The number of semi-synthetic and synthetic opioid and heroin deaths in the United States has risen from 2017 to the present compared to a decline in deaths related to prescription opioids (NIDA, 2023). The trends of drug abuse and drug-related deaths are national public health problems. The trends are staggering; since 2012, drug-related deaths have experienced nearly a 14- fold increase (NIDA, 2023).
Page 32
Book Code: RPTTX2024
EliteLearning.com/Pharmacy-Technician
Powered by FlippingBook